168 related articles for article (PubMed ID: 26942099)
1. Motor neuron degeneration in spinal and Bulbar Muscular Atrophy is a skeletal muscle-driven process: Relevance to therapy development and implications for related motor neuron diseases.
Cortes CJ; La Spada AR
Rare Dis; 2014; 2(1):e962402. PubMed ID: 26942099
[TBL] [Abstract][Full Text] [Related]
2. X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease.
Gromova A; Cha B; Robinson EM; Strickland LM; Nguyen N; ElMallah MK; Cortes CJ; La Spada AR
Acta Neuropathol Commun; 2023 Jun; 11(1):90. PubMed ID: 37269008
[TBL] [Abstract][Full Text] [Related]
3. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.
Cortes CJ; Ling SC; Guo LT; Hung G; Tsunemi T; Ly L; Tokunaga S; Lopez E; Sopher BL; Bennett CF; Shelton GD; Cleveland DW; La Spada AR
Neuron; 2014 Apr; 82(2):295-307. PubMed ID: 24742458
[TBL] [Abstract][Full Text] [Related]
4. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy.
Sahashi K; Katsuno M; Hung G; Adachi H; Kondo N; Nakatsuji H; Tohnai G; Iida M; Bennett CF; Sobue G
Hum Mol Genet; 2015 Nov; 24(21):5985-94. PubMed ID: 26231218
[TBL] [Abstract][Full Text] [Related]
5. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
6. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
7. Exercise attenuates polyglutamine-mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy.
Hirunagi T; Nakatsuji H; Sahashi K; Yamamoto M; Iida M; Tohnai G; Kondo N; Yamada S; Murakami A; Noda S; Adachi H; Sobue G; Katsuno M
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):159-172. PubMed ID: 37937369
[TBL] [Abstract][Full Text] [Related]
8. A mouse model of spinal and bulbar muscular atrophy.
McManamny P; Chy HS; Finkelstein DI; Craythorn RG; Crack PJ; Kola I; Cheema SS; Horne MK; Wreford NG; O'Bryan MK; De Kretser DM; Morrison JR
Hum Mol Genet; 2002 Sep; 11(18):2103-11. PubMed ID: 12189162
[TBL] [Abstract][Full Text] [Related]
9. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
Katsuno M; Adachi H; Tanaka F; Sobue G
J Mol Med (Berl); 2004 May; 82(5):298-307. PubMed ID: 15133611
[TBL] [Abstract][Full Text] [Related]
10. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
Cortes CJ; La Spada AR
Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.
Sopher BL; Thomas PS; LaFevre-Bernt MA; Holm IE; Wilke SA; Ware CB; Jin LW; Libby RT; Ellerby LM; La Spada AR
Neuron; 2004 Mar; 41(5):687-99. PubMed ID: 15003169
[TBL] [Abstract][Full Text] [Related]
12. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.
Lieberman AP; Yu Z; Murray S; Peralta R; Low A; Guo S; Yu XX; Cortes CJ; Bennett CF; Monia BP; La Spada AR; Hung G
Cell Rep; 2014 May; 7(3):774-84. PubMed ID: 24746732
[TBL] [Abstract][Full Text] [Related]
13. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Inukai A; Sobue G
Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
16. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy.
Montague K; Malik B; Gray AL; La Spada AR; Hanna MG; Szabadkai G; Greensmith L
Brain; 2014 Jul; 137(Pt 7):1894-906. PubMed ID: 24898351
[TBL] [Abstract][Full Text] [Related]
18. AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.
Forouhan M; Lim WF; Zanetti-Domingues LC; Tynan CJ; Roberts TC; Malik B; Manzano R; Speciale AA; Ellerington R; Garcia-Guerra A; Fratta P; Sorarú G; Greensmith L; Pennuto M; Wood MJA; Rinaldi C
Acta Neuropathol; 2022 Jun; 143(6):713-731. PubMed ID: 35522298
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
[TBL] [Abstract][Full Text] [Related]
20. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
Pennuto M; Gozes I
J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
